CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total
Balance at beginning of period at Dec. 31, 2022	$ 1	$ 880,832	$ (897)	$ (682,315)	$ 197,621
Balance at beginning of period (in shares) at Dec. 31, 2022	66,688,647
Increase (Decrease) in Stockholders' Equity
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units		(8)			(8)
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units (in shares)	806,242
Issuance of common stock, net of offering costs		26,714			26,714
Issuance of common stock, net of offering costs (In shares)	3,400,000
Unrealized gain on marketable securities			791		791
Stock-based compensation expense		20,542			20,542
Net loss				(88,481)	(88,481)
Balance at end of period at Dec. 31, 2023	$ 1	928,080	(106)	(770,796)	$ 157,179
Balance at end of period (in shares) at Dec. 31, 2023	70,894,889				70,894,889
Increase (Decrease) in Stockholders' Equity
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units		(377)			$ (377)
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units (in shares)	1,399,680
Issuance of common stock, net of offering costs		74,913			74,913
Issuance of common stock, net of offering costs (In shares)	35,555,555
Issuance of common stock purchase warrants		44,845			44,845
Unrealized gain on marketable securities			203		203
Stock-based compensation expense		10,856			10,856
Net loss				(132,065)	(132,065)
Balance at end of period at Dec. 31, 2024	$ 1	$ 1,058,317	$ 97	$ (902,861)	$ 155,554
Balance at end of period (in shares) at Dec. 31, 2024	107,850,124				107,850,124